What are the key supply-demand and regulatory factors shaping China's cefradine market outlook?
For buyers, the key risk is not supply shortage but quality variability among smaller API producers during price downturns. When margins compress, some manufacturers may cut corners on impurity controls. Prudent procurement should prioritize suppliers with consistent regulatory compliance records, even if their quotes are slightly higher, to avoid batch rejections downstream.
